miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

PLoS One · 2013 · PMC3789742 · PMID 24098452

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

No significant results were detected for MEGF9 and CCNJ, although a clear trend for the MEGF9 protein could be observed ( Figure 7C and data not shown).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.